Peter Nordkild

MD, with 20 years of experience from pharmaceutical companies Novo Nordisk and Ferring Pharmaceuticals. Prior to joining Asarina, Peter spent 10 years in biotechnology as CEO of Nasdaq listed Egalet and as serial Danish biotech entrepreneur. Founder or co-founder of ARTS Biologics in fertility treatment; Adenium Biotech in antimicrobial peptides and multi resistant bacteria and Defensin Therapeutics in microbiota modulating defensins.